HEPARIN MARKET ANALYSIS

Heparin Market, by Product Type (Unfractionated Heparin (UH), Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMW)), by Dosage Form (Injection, and Solutions), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026

Published In : May 2019
Code : CMI2602
Pages :149
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Heparin Market - Regional Insights

On the basis of region, the global heparin market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe heparin market is expected to generate significant revenue share during the forecast period, owing to growing geriatric population and rising prevalence of long-term survivors of acute myocardial infarction (AMI). Survivors of AMI are at high risk of a recurrent myocardial infarction, as well as other manifestations of cardiovascular disease such as stroke. According to Lancet journal, 2017 report, acute myocardial infarction is the leading cause of hospital admissions and mortality in the UK and across the world.

Asia Pacific heparin market is expected to grow at the highest rate during the forecast period, owing to increasing incidence of myocardial infarction among regional population. According to a study published by National Center for Biotechnology Information (NCBI) in 2015, Asian population is more susceptible to MI than white people. There are 50% higher cases of MI in South Asians than in white people in the UK.